Literature DB >> 11078312

Electron-beam computed tomography in the evaluation of patients with chest pain.

T C Andrews.   

Abstract

Electron-beam computed tomography is a promising technology for the noninvasive evaluation of patients with suspected coronary artery disease. However, at the present time there is insufficient clinical evidence to support its widespread use as a screening tool for evaluation of patients with chest pain.

Entities:  

Mesh：

Year:  2000        PMID： 11078312     DOI： 10.1016/s0002-9149(99)00752-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  3 in total

1.  Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging.

Authors:  Matthijs Oudkerk; Arthur E Stillman; Sandra S Halliburton; Willi A Kalender; Stefan Möhlenkamp; Cynthia H McCollough; Rozemarijn Vliegenthart; Leslee J Shaw; William Stanford; Allen J Taylor; Peter M A van Ooijen; Lewis Wexler; Paolo Raggi
Journal:  Eur Radiol       Date:  2008-07-24       Impact factor: 5.315

Review 2.  Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging.

Authors:  Matthijs Oudkerk; Arthur E Stillman; Sandra S Halliburton; Willi A Kalender; Stefan Möhlenkamp; Cynthia H McCollough; Rozemarijn Vliegenthart; Leslee J Shaw; William Stanford; Allen J Taylor; Peter M A van Ooijen; Lewis Wexler; Paolo Raggi
Journal:  Int J Cardiovasc Imaging       Date:  2008-05-27       Impact factor: 2.357

3.  Cardiac computed tomography in patients with symptomatic new-onset atrial fibrillation, rule-out acute coronary syndrome, but with intermediate pretest probability for coronary artery disease admitted to a chest pain unit.

Authors:  Matthias Koopmann; Liane Hinrichs; Jan Olligs; Michael Lichtenberg; Lars Eckardt; Dirk Böse; Stefan Möhlenkamp; Johannes Waltenberger; Frank Breuckmann
Journal:  Eur J Med Res       Date:  2018-01-24       Impact factor: 2.175
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.